Fujifilm Diosynth Biotechnologies announced a new $1.2 billion investment on Thursday to expand its large-scale biomanufacturing facility in Holly Springs, NC, with plans to add 680 jobs by 2031.
The site, which won’t open officially until 2025, will add eight more 20,000-liter mammalian cell culture bioreactors by 2028 to the eight existing 20,000-liter bioreactors. The number of jobs at the Holly Springs site will now total 1400, the company said.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.